Law360, New York (July 21, 2011, 3:47 PM EDT) -- Medicis Pharmaceutical Corp. launched three lawsuits in New York on Tuesday in an effort to block competitors from producing generic versions of its seborrheic dermatitis treatment Loprox Shampoo.
The specialty pharmaceutical company filed complaints against Nycomed US Inc., Perrigo Co. Inc. and Taro Pharmaceuticals USA Inc. claiming the defendants violated its patent for the prescription shampoo.
The lawsuits allege the three have marketed generic products that infringe Medicis' patent, U.S. Patent Number 7,981,909, titled "Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis."
Seborrheic dermatitis is a skin disorder whose symptoms can include flaking, itching, scaling, redness of the scalp and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!